Table 2.
Predicted Probability (%) and 95% Confidence Interval for Any Stage B Left Ventricular Abnormality (Adverse Geometry, Ejection Fraction <50%, and/or Diastolic Dysfunction†, by Age | |||||
---|---|---|---|---|---|
40 years | 45 years | 50 years | 55 years | 60 years | |
N with outcome/N total‡ | 45/183 | 258/883 | 603/1825 | 541/1360 | 102/250 |
Overall | 19.5 (16.5–22.9) | 24.8 (22.3–27.4) | 30.8 (29.1–32.6) | 37.7 (36.0–39.4) | 45.0 (42.0–48.1) |
Black men | 27.0 (19.3–36.3) | 32.8 (26.8–39.3) | 39.1 (35.1–43.2) | 45.8 (41.2–50.4) | 52.7 (44.9–60.3) |
Black women | 25.3 (19.4–32.3) | 32.8 (28.0–37.9) | 41.3 (38.0–44.6) | 50.4 (46.8–53.9) | 59.4 (53.6–65.0) |
White men | 15.1 (10.1–21.8) | 19.7 (15.3–25.0) | 25.2 (22.0–28.8) | 31.7 (28.7–35.0) | 39.1 (33.4–45.0) |
White women | 7.7 (4.9–11.8) | 12.2 (9.1–16.1) | 18.8 (16.1–21.8) | 27.8 (25.3–30.5) | 39.1 (33.9–44.6) |
An age-squared term was tested and not significant (P>0.05) so was not included in models.
Diastolic dysfunction on the basis of full 2016 American Society of Echocardiography criteria, among participants with ejection fraction ≥50%. Required variables were only available at years 25 and 30; probabilities are thus restricted to ages 40 to 60 years. See text (Methods) for details.